Publicaciones (50) Publicaciones en las que ha participado algún/a investigador/a

2012

  1. A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer

    PLoS ONE, Vol. 7, Núm. 9

  2. A comparison of Val81Met and other polymorphisms of alcohol metabolising genes in patients and controls in Northern Spain

    Alcohol, Vol. 46, Núm. 5, pp. 427-431

  3. Accurate fat fraction quantification by multiecho gradient-recalled-echo magnetic resonance at 1.5 T in rats with nonalcoholic fatty liver disease

    European Journal of Radiology, Vol. 81, Núm. 6, pp. 1122-1127

  4. Adjuvant and neoadjuvant treatment in pancreatic cancer

    World Journal of Gastroenterology, Vol. 18, Núm. 14, pp. 1565-1572

  5. Aféresis en enfermedad inflamatoria intestinal. ¿Una opción válida?

    Gastroenterologia y Hepatologia, Vol. 35, Núm. 1, pp. 22-31

  6. Association of alcohol dehydrogenase polymorphisms and life-style factors with excessive alcohol intake within the Spanish population (EPIC-Spain)

    Addiction, Vol. 107, Núm. 12, pp. 2117-2127

  7. COGENT (COlorectal cancer GENeTics) revisited

    Mutagenesis, Vol. 27, Núm. 2, pp. 143-151

  8. Changes in the levels of thioredoxin and indoleamine-2,3-dioxygenase activity in plasma of patients with colorectal cancer treated with chemotherapy

    Biochemistry and Cell Biology, Vol. 90, Núm. 2, pp. 173-178

  9. Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer

    Drug Metabolism Reviews, Vol. 44, Núm. 2, pp. 148-172

  10. Clinical practice Guidelines: Quality of colonoscopy in colorectal cancer screening

    Endoscopy, Vol. 44, Núm. 4, pp. 444-451

  11. Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening

    Gastroenterological Endoscopy, Vol. 54, Núm. 4, pp. 1510

  12. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening

    New England Journal of Medicine, Vol. 366, Núm. 8, pp. 697-706

  13. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer

    Gut, Vol. 61, Núm. 6, pp. 865-872

  14. Effect of neoadjuvant chemotherapy in hepatic steatosis

    Chemotherapy, Vol. 58, Núm. 2, pp. 89-94

  15. Effectiveness of infliximab after adalimumab failure in Crohn's disease

    World Journal of Gastroenterology, Vol. 18, Núm. 37, pp. 5219-5224

  16. Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation

    Liver Transplantation, Vol. 18, Núm. 1, pp. 45-52

  17. Efficacy of intralesional corticosteroid injection in endoscopic treatment of esophageal strictures

    Surgical Laparoscopy, Endoscopy and Percutaneous Techniques, Vol. 22, Núm. 6, pp. 518-522

  18. Enfermedades hepáticas de origen metabólico

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 11, Núm. 10, pp. 590-600

  19. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures

    Alimentary Pharmacology and Therapeutics, Vol. 35, Núm. 8, pp. 941-947

  20. Gastrointestinal bleeding caused by primary small bowel lymphoma in a patient who received a renal transplant

    Clinical Gastroenterology and Hepatology, Vol. 10, Núm. 1